NEWS & MEDIA

10 - 11 mai 2017 Read more

NEOVACS AND LUPUS EUROPE JOIN VOICES ON WORLD LUPUS DAY

Interview with Anne Charlet, Vice Chair of the Lupus Europe association:  

20 - 24 mars 2017 Read more

NEOVACS TO PRESENT IFNα KINOID TECHNOLOGY AT UPCOMING KEYSTONE SYMPOSIA CONFERENCE: “Type I Interferon: Friend and Foe Alike”

Dr. Grouard-Vogel will give a presentation entitled, “Overexpression of IFNalpha and Derived Diseases: Innovative Approach with a Therapeutic Vaccine IFNalpha Kinoid,” during the “Tailoring Type I IFN Interventions to Achieve Cure” session on Thursday, March 23, 2017, from 5:00 – 6:45 PM ET. www.keystonesymposia.com

21 novembre 2017 Read more

NEOVACS TO PRESENT CLINICAL DEVELOPMENT UPDATE ON IFNα KINOID IN DERMATOMYOSIS

Paris and Boston, May 4, 2017 – 8:00 AM CET – Neovacs (Alternext Paris: ALNEV), a leader in active immunotherapies for the treatment of autoimmune diseases, today announced that Thérèse Croughs, M.D., Chief Medical Officer of Neovacs, will present an update on the clinical development of the Company’s IFNα Kinoid in dermatomyositis at the 2nd […]